PDGF receptor beta binding polypeptides
US9416179B2 · kind B2 · utility
1Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2012 |
| Grant date | Aug 16, 2016 |
| Priority date | — |
| Expiry date | Jun 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides binding polypeptides (e.g., antibodies or fragments thereof) that specifically bind to a target antigen (e.g., a human antigen, e.g., human PDGFRβ) with high affinity. The invention also provides, libraries of binding polypeptides, pharmaceutical compositions, as well as nucleic acids encoding binding polypeptides, recombinant expression vectors and host cells for making such binding polypeptides. Methods of using binding polypeptide of the invention to diagnose and treat disease are also encompassed by the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.